Nuventra Announces Addition of Chuck Poole and Howard A. Ball to its Growing Team of Clinical Pharmacology Experts
Nuventra is pleased to announce the addition of two experienced scientists, Chuck Poole, B.S. and Howard A. Ball, Ph.D., to its growing team of senior consultants. Both bring more than…
Read More
Nuventra Renovates & Expands Durham Headquarters to Accommodate Growth
Nuventra Pharma Sciences is excited to announce the completion of its newly renovated company headquarters in Durham, NC. The expanded and redesigned 15,000 square foot space features eight conference rooms…
Read More
Nuventra Pharma Sciences to Present and Exhibit at ASCPT Annual Meeting
Nuventra is proud to announce its participation at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting and Exposition on March 13 – 16, 2019 in Washington, D.C. Nuventra will…
Read More
Nuventra Pharma Sciences Named a TBJ Fast 50 Award Winner for Third Consecutive Year
Nuventra Pharma Sciences is pleased to announce that it has been ranked as a part of the Triangle Business Journal’s Fast 50 List honoring the 50 fastest growing privately held…
Read More
Former FDA Reviewers Brian Furmanski & Gene Williams Join Nuventra Pharma Sciences as Senior Consultants
Nuventra Pharma Sciences is pleased to announce the addition of two former FDA reviewers, Brian Furmanski Ph.D. and Gene Williams Ph.D., to its growing team of experienced consultants. Both offer a…
Read More
Nuventra’s Senior Consultants to Speak about the Path to IND at September’s LaunchBio Event
Nuventra Pharma Sciences will present at LaunchBio’s Larger Than Life Science Event on Thursday, September 6, 2018. This monthly event series features networking opportunities, workshops, and panel discussions led by…
Read More
Nuventra Ranks on Inc. 5000 List for Fifth Consecutive Year
Inc. Magazine announced today that Nuventra Pharma Sciences has once again ranked on the Inc. 5000 list for 2018. This marks the fifth year in a row that Nuventra has…
Read More